Insider trades › Eli Lilly › Lucas Montarce

Lucas Montarce: Eli Lilly stock transactions

Lucas Montarce (EVP & CFO at Eli Lilly) reported 2 transactions in LLY stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Montarce Lucas.

$0open-market sales (0 shares)
$0open-market purchases (0 shares)
2026-11-01most recent transaction

Transactions

Date Transaction Shares Price Value Filing
Nov 1, 2026 Option or RSU exercise 1,610 — — Form 4 ↗
Nov 1, 2026 Shares withheld for tax 678 $1417.54 — Form 4 ↗

Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.